Messina, O D, Vidal, L F, Vidal, M V, Bultink, I E M, Raterman, H G & Lems, W 2021, ' Management of glucocorticoid-induced osteoporosis ', Aging Clinical and Experimental Research, vol. 33, no. 4, pp. 793-804 . https://doi.org/10.1007/s40520-021-01823-0
Arthritis & Rheumatology (Hoboken, N.j.) Arthritis and Rheumatology, 71(7), 1174-1184. John Wiley and Sons Ltd Arthritis & Rheumatology, 71(7), 1174-1184. Wiley Saag, K G, Pannacciulli, N, Geusens, P, Adachi, J D, Messina, O D, Morales-Torres, J, Emkey, R, Butler, P W, Yin, X & Lems, W F 2019, ' Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four–Month Randomized, Double-Blind, Double-Dummy Trial ', Arthritis and Rheumatology, vol. 71, no. 7, pp. 1174-1184 . https://doi.org/10.1002/art.40874
Osteoporosis International Osteoporosis International, 30(1), 45-57. Springer-Verlag London Ltd. Osteoporosis International, Vol. 30, No 1 (2019) pp. 45-57
RMD Open RMD Open, Vol 7, Iss 2 (2021) Aletaha, D, Westhovens, R, Gaujoux-viala, C, Adami, G, Matsumoto, A, Bird, P, Messina, O D, Buch, M H, Bartok, B, Yin, Z, Guo, Y, Hendrikx, T & Burmester, G R 2021, ' Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 ', RMD Open, vol. 7, no. 2, pp. e001621 . https://doi.org/10.1136/rmdopen-2021-001621